The NDA was submitted to the FDA in November.

CHN also offers 17 pediatric emergency medication specialists who personnel one hospital in Las Vegas and one in Lafayette, Louisiana. Pediatric emergency medication is a fresh clinical program for Pediatrix. For the most part of the 11 hospitals of which the combined group methods, CHN manages multiple pediatric specialty solutions. Dr. MEDNAX acquired CHN for cash, and the transaction is expected to be accretive to its revenue immediately. No additional terms of the transaction were disclosed. With the acquisition of CHN, MEDNAX provides completed eight doctor group practice acquisitions during 2009.. Centocor Ortho Biotech Items withdraws NDA for trabectedin for treatment of women with ROC Centocor Ortho Biotech Items, L.P., today announced that it has voluntarily withdrawn the brand new Drug Program for trabectedin for the treatment of females with recurrent ovarian cancers .S.The study will accrue approximately 36 individuals with solid tumor cancers expressing the NY-ESO-1 antigen and will follow each subject for half a year post-treatment. The study has been conducted at multiple scientific sites in the usa, including Yale University, Henry Ford Health Program and Cornell University. This technology will take benefit of many important features of monoclonal antibodies, including their specific targeting ability, which helps concentrate the disease fighting capability on the cancers..